Dyadic International, Inc. (DYAI) Stock Analysis & Investment Frameworks
Dyadic International, Inc. (DYAI) stock analysis on Invetso. Review Dyadic International, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Dyadic International, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Dyadic International, Inc. Key Financial Metrics
- Market Cap: $13.63M
- Revenue: $1.23M
- ROE: -2918.10%
- ROIC: -278.95%
- Dividend Yield: N/A
About Dyadic International, Inc.
Dyadic International, Inc. operates as a U.S.-based biotechnology platform company, specializing in the development, production, and commercialization of enzymes and other proteins. Its core activities are underpinned by a patented and proprietary C1 platform, alongside other advanced technologies. This technological foundation drives their research, development, and commercial endeavors, focusing on the creation and manufacturing of various human and animal vaccines and pharmaceutical products. These offerings span a wide range of biological therapeutics, including virus-like particles (VLPs), antigens, monoclonal, bi-specific, and tri-specific antibodies, Fab antibody fragments, Fc-fusion proteins, biosimilars, biobetters, and diverse therapeutic enzymes and proteins. A key pipeline asset is DYAI-100, a SARS-CoV-2-RBD antigen vaccine candidate. This candidate is currently slated for a first-in-human Phase 1 clinical trial, with the objective of establishing proof of concept for the development of next-generation, multivariant COVID-19 vaccine candidates. Dyadic also maintains several strategic alliances, including a research and development agreement with VTT Technical Research Centre of Finland, Ltd., a strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U., and a collaboration with Syngene International Limited. Established in 1979, the company is headquartered in Jupiter, Florida.
Dyadic International, Inc. Investment Frameworks
Invetso analyzes Dyadic International, Inc. (DYAI) across the following frameworks:
- Dyadic International, Inc. 10Y Growth Potential
- Dyadic International, Inc. Scenario Analysis
- Dyadic International, Inc. Risks & Opportunities
- Dyadic International, Inc. Economic Moat
- Dyadic International, Inc. Business Model
- Dyadic International, Inc. Management
- Dyadic International, Inc. SWOT Analysis
- Dyadic International, Inc. Porter's 5 Forces
- Dyadic International, Inc. PESTLE Analysis
- Dyadic International, Inc. ESG Analysis